
BOLD Capital Partners
BOLD Capital Partners is an early-stage venture capital firm investing in life sciences, healthcare, and frontier technology. Founded in 2015 and based in Santa Monica, California, the firm focuses on exponential technologies converging the physical, digital, virtual, and biological worlds to solve humanity's greatest challenges.
Deal activity decreased year-over-year (4 deals in the last 12 months vs 12 prior). Their most common stage is series-a (45% of deals). Average disclosed round size is $35.0M (across 87 rounds with reported amounts).
Portfolio
61
Fund Size
—
Top Stage
Series A
Last 12 Mo
4
Team
Emilio Diez Barroso
General Partner
Neal Bhadkamkar
General Partner
Daglar Cizmeci
Venture Partner
Helen McBride
Partner
Matt Grob
Venture Partner
Peter Diamandis
Partner
Rana El Kaliouby
Venture Partner
Ysette Witteveen
Venture Partner
Felicia Hsu
Principal
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| Series B | $27.4M | Mar 2026 | |
| Series A | $6M | Feb 2026 | |
| Seed | $10M | Jan 2026 | |
| Series B | — | Sep 2025 | |
| Unknown | $20M | Aug 2025 | |
| Series B | — | Jul 2025 | |
| Series A | $45M | Jul 2025 | |
| SSyntis Bio | Series A | $38M | Jul 2025 |
| Series A | $43.1M | Mar 2025 | |
| Series A | — | Feb 2025 | |
| EEsperto | Series A | $15.2M | Feb 2025 |
| Series C | $200M | Jan 2025 | |
| CColossal Biosciences | Series C | $200M | Jan 2025 |
| RRembrand, Inc. | Series A | $23M | Jan 2025 |
| Series B | $20M | Jan 2025 | |
| Series A | $20M | Jan 2025 | |
| Series A | $15.2M | Jan 2025 | |
| Unknown | — | Sep 2024 | |
| Series A | $11M | Sep 2024 | |
| Series C | $33M | May 2024 | |
| Series A | $16M | Jan 2024 | |
| Unknown | $100M | Jan 2024 | |
| Series A | — | Jan 2024 | |
| Series A | $11M | Jan 2024 | |
| Series C | $52M | Sep 2023 |
Top Co-Investors
Last updated: 7 October 2026